426 filings
10-K
2023 FY
HEPA
Hepion Pharmaceuticals Inc
Annual report
16 Apr 24
4:53pm
NT 10-K
HEPA
Hepion Pharmaceuticals Inc
1 Apr 24
Notice of late annual filing
4:30pm
8-K
HEPA
Hepion Pharmaceuticals Inc
6 Mar 24
Departure of Directors or Certain Officers
4:15pm
8-K
HEPA
Hepion Pharmaceuticals Inc
20 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
956gpeyi70z qq06
7 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
y0ob3
3 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
r6fkwc1p3 ed9
7 Dec 23
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
8:41am
NT 10-Q
tua 0rk694mfae
14 Nov 23
Notice of late quarterly filing
4:46pm
EFFECT
4kiysz9c2yrdhj8
9 Nov 23
Notice of effectiveness
12:15am
CORRESP
giia zoldt
6 Nov 23
Correspondence with SEC
12:00am
UPLOAD
e8iqs0dm pw
3 Nov 23
Letter from SEC
12:00am
D
7fp6hxtlp0zo
3 Oct 23
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
5:22pm
8-K
cy4kww02k0ywd qq
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
kw564c d48hpwf07b
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
6tsylrtk02
6 Sep 23
Departure of Directors or Certain Officers
4:40pm
8-K
lvagc gzyb4
24 Jul 23
Regulation FD Disclosure
4:04pm